bluebird bio Inc
Change company Symbol lookup
Select an option...
BLUE bluebird bio Inc
MSFT Microsoft Corp
ACC American Campus Communities Inc
PNFP Pinnacle Financial Partners Inc
SYF Synchrony Financial
TRV Travelers Companies Inc
IBM International Business Machines Corp
T AT&T Inc
MRK Merck & Co Inc
PFE Pfizer Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

bluebird bio, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. The Company's clinical programs in severe genetic diseases include its LentiGlobin product candidate to treat transfusion-dependent b-thalassemia and to treat severe sickle cell disease (SCD) and its Lenti-D product candidate to treat cerebral adrenoleukodystrophy (CALD). Its programs in oncology focuses on developing T cell-based immunotherapies, including chimeric antigen receptor (CAR) and T cell receptor (TCR) T cell therapies. bb2121, its lead product candidate in oncology, is a CAR T cell product candidate for the treatment of multiple myeloma. It also has discovery research programs utilizing megaTALs/homing endonuclease gene editing technologies for use across its pipeline.

Closing Price
$27.86
Day's Change
-0.12 (-0.43%)
Bid
--
Ask
--
B/A Size
--
Day's High
28.45
Day's Low
27.24
Volume
(Light)
Volume:
989,287

10-day average volume:
1,335,141
989,287
  • Prev Close
    27.98
  • Today's Open
    27.50
  • Day's Range
    27.24-28.45
  • Avg Vol (10-day)
    1.3M
  • Last (time)
    3:59p ET 04/20/21
  • Last (size)
    100
  • 52-Wk Range
    24.24 - 72.51
    LowHigh
  • (06/05/20 - 02/23/21)
    14.93%
  • 72.7%
  • Market Cap
    1.9B
  • Shares Outstanding
    67.1M
  • -9.95
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.7
  • 81.74
  • (% of float 03/31/21)
    10.20

Latest News

April 20, 2021
7:30 am ET
BusinessWire
April 14, 2021
7:00 am ET
BusinessWire
April 13, 2021
4:24 pm ET
Newsfile
3:20 pm ET
Accesswire
2:47 pm ET
Globe Newswire
10:53 am ET
Accesswire
10:03 am ET
Newsfile
9:43 am ET
Newsfile
9:41 am ET
Accesswire
9:01 am ET
Newsfile
6:30 am ET
Accesswire
1:00 am ET
Accesswire
April 12, 2021
5:27 pm ET
Newsfile
4:00 pm ET
PR Newswire
3:48 pm ET
PR Newswire
3:22 pm ET
Accesswire
1:25 pm ET
Accesswire
12:51 pm ET
Accesswire
11:20 am ET
Accesswire
9:58 am ET
Newsfile
9:00 am ET
Globe Newswire
8:01 am ET
Newsfile
6:11 am ET
Newsfile
12:06 am ET
Accesswire
April 11, 2021
1:00 pm ET
Accesswire
6:22 am ET
PR Newswire
April 09, 2021
9:00 pm ET
Globe Newswire
6:28 pm ET
Newsfile
5:00 pm ET
Globe Newswire
3:14 pm ET
Newsfile
1:45 pm ET
Accesswire
11:51 am ET
Accesswire
10:59 am ET
Newsfile
10:51 am ET
Accesswire
10:30 am ET
Accesswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.